354 related articles for article (PubMed ID: 28460457)
1. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
[TBL] [Abstract][Full Text] [Related]
3. RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.
Quarni W; Lungchukiet P; Tse A; Wang P; Sun Y; Kasiappan R; Wu JY; Zhang X; Bai W
J Steroid Biochem Mol Biol; 2017 Oct; 173():157-167. PubMed ID: 28159673
[TBL] [Abstract][Full Text] [Related]
4. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
7. Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt/β-catenin signaling.
Zheng Y; Trivedi T; Lin RC; Fong-Yee C; Nolte R; Manibo J; Chen Y; Hossain M; Horas K; Dunstan C; Zhou H; Seibel MJ
Bone Res; 2017; 5():17023. PubMed ID: 28944088
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
Keith ME; LaPorta E; Welsh J
Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.
Tavera-Mendoza LE; Westerling T; Libby E; Marusyk A; Cato L; Cassani R; Cameron LA; Ficarro SB; Marto JA; Klawitter J; Brown M
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2186-E2194. PubMed ID: 28242709
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
11. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling.
Zheng W; Duan B; Zhang Q; Ouyang L; Peng W; Qian F; Wang Y; Huang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30314996
[No Abstract] [Full Text] [Related]
14. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
15. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
Alimirah F; Peng X; Gupta A; Yuan L; Welsh J; Cleary M; Mehta RG
Exp Cell Res; 2016 Nov; 349(1):15-22. PubMed ID: 27693451
[TBL] [Abstract][Full Text] [Related]
17. Function of the vitamin D endocrine system in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-3 receptor as a target for breast cancer prevention.
Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
[TBL] [Abstract][Full Text] [Related]
20. Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization.
Horas K; Zheng Y; Fong-Yee C; Macfarlane E; Manibo J; Chen Y; Qiao J; Gao M; Haydar N; McDonald MM; Croucher PI; Zhou H; Seibel MJ
J Bone Miner Res; 2019 Sep; 34(9):1721-1732. PubMed ID: 30995345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
